According to Seagen
's latest financial reports the company has $2.55 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $2.80 B | -8.53% |
2021-12-31 | $3.06 B | -12.13% |
2020-12-31 | $3.48 B | 85.9% |
2019-12-31 | $1.87 B | 47.28% |
2018-12-31 | $1.27 B | 88.02% |
2017-12-31 | $0.67 B | 6.86% |
2016-12-31 | $0.63 B | -7.56% |
2015-12-31 | $0.68 B | 225.33% |
2014-12-31 | $0.21 B | -8.41% |
2013-12-31 | $0.23 B | 1.79% |
2012-12-31 | $0.22 B | 3.34% |
2011-12-31 | $0.21 B | 35.5% |
2010-12-31 | $0.16 B | -21.67% |
2009-12-31 | $0.20 B | 160.95% |
2008-12-31 | $79.01 M | 46.37% |
2007-12-31 | $53.98 M | -38.81% |
2006-12-31 | $88.23 M | 16.93% |
2005-12-31 | $75.45 M | -27.33% |
2004-12-31 | $0.10 B | 38.67% |
2003-12-31 | $74.87 M | 60.33% |
2002-12-31 | $46.7 M | -23.03% |
2001-12-31 | $60.67 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 3,400.91% | ๐บ๐ธ USA |
AbbVie ABBV | $10.39 B | 307.66% | ๐บ๐ธ USA |
Biogen BIIB | $14.79 B | 480.27% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $29.48 B | 1,056.08% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.28 B | 538.64% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | $26.8 M | -98.95% | ๐บ๐ธ USA |
ImmunoGen
IMGN | $0.56 B | -77.98% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.42 B | -83.17% | ๐บ๐ธ USA |